- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Programmed Death-Ligand 1 (PDL1, PD-L1)
Total 50585 results
-
Centre Leon BerardNETRIS PharmaRecruitingAdvanced Solid Tumors | Metastatic Solid TumorsFrance
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingNonsquamous Non-small Cell Lung CancerUnited States, Argentina, Australia, Canada, Chile, China, France, Germany, Israel, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Turkey, United Kingdom
-
Merck Sharp & Dohme LLCEisai Inc.CompletedNon-small Cell Lung CancerChina, Israel, United States, Australia, Canada, Colombia, Estonia, France, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Poland, Russian Federation, Taiwan, Turkey, Ukraine
-
Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Australia, Canada, Chile, China, France, Greece, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, South Africa, Spain, Sweden
-
Merck Sharp & Dohme LLCEisai Inc.CompletedAdvanced MelanomaCanada, United States, Australia, Spain, Sweden
-
Merck Sharp & Dohme LLCActive, not recruitingMelanoma | Carcinoma, Non-Small-Cell LungIndia
-
Merck Sharp & Dohme LLCCompletedMelanomaAustralia, South Africa, Spain, Sweden
-
Merck Sharp & Dohme LLCNot yet recruitingEsophageal Cancer | Esophageal Neoplasms | Gastroesophageal Adenocarcinoma | Gastroesophageal Junction
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)China, Turkey, Australia, United States, Chile, Taiwan, Denmark, France, Spain, Argentina, Italy, Netherlands, Thailand, Korea, Republic of, Czechia, Portugal, Canada, United Kingdom
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate Cancer
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
Merck Sharp & Dohme LLCActive, not recruiting
-
Merck Sharp & Dohme LLCActive, not recruitingSmall Cell Lung CarcinomaPoland, Russian Federation, United States, Australia, Austria, Canada, Hungary, Israel, Italy, Korea, Republic of, Spain, Switzerland
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingColorectal NeoplasmsUnited States, Argentina, Australia, Canada, China, Denmark, Germany, Israel, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Non Small Cell Lung CancerDenmark, United States, Argentina, Australia, Austria, Belgium, Brazil, Finland, France, Germany, Israel, Italy, Korea, Republic of, Malaysia, Poland, Russian Federation, Spain, Switzerland, Taiwan, Thailand
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-Small-Cell Lung | Solid Tumor | Pharmacokinetics | Triple Negative Breast NeoplasmsUnited States, Chile, Israel, Korea, Republic of, Netherlands, Spain, Taiwan
-
Merck Sharp & Dohme LLCRecruitingBreast NeoplasmsIsrael, United States, Taiwan, Hong Kong, Korea, Republic of, Switzerland, Costa Rica, Malaysia
-
Merck Sharp & Dohme LLCCompletedProstatic NeoplasmsUnited States, Argentina, Australia, Austria, Brazil, Canada, Chile, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom, New Zealand
-
Tongji HospitalNational Natural Science Foundation of ChinaRecruitingEsophageal Squamous Cell Carcinoma | Neoadjuvant TherapiesChina
-
Merck Sharp & Dohme LLCNot yet recruiting
-
Merck Sharp & Dohme LLCModernaTX, Inc.RecruitingBladder CancerCanada, New Zealand, Germany, Chile, Australia, United States, Poland, Spain, Sweden, France, Italy
-
Merck Sharp & Dohme LLCRecruitingAdvanced or Metastatic Solid TumorsCanada, Switzerland, United States
-
Merck Sharp & Dohme LLCRecruitingLung Neoplasms | Non-Small-Cell Lung CarcinomaUnited States, Brazil, Canada, Chile, China, Guatemala, Hong Kong, Hungary, Japan, Korea, Republic of, Malaysia, Mexico, Peru, Russian Federation, South Africa, Taiwan, Thailand, Ukraine, Romania, Dominican Republic, Philippines, ... and more
-
Merck Sharp & Dohme LLCGOG Foundation; European Network of Gynaecological Oncological Trial Groups...Active, not recruitingEndometrial NeoplasmsAustralia, United States, Germany, Israel, Korea, Republic of, Poland, Turkey, Belgium, Brazil, Canada, Chile, China, Czechia, Denmark, Finland, Hungary, Ireland, Italy, Japan, Netherlands, New Zealand, Norway, Russian Federation, Spain, Swed... and more
-
Peking UniversityNot yet recruitingEsophageal Squamous Cell CarcinomaChina
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Renal CellSpain, United States, Australia, Canada, Chile, Colombia, France, Hungary, Israel, Korea, Republic of, Netherlands, New Zealand, Poland, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Renal CellUnited States, Australia, Canada, Chile, France, Hungary, Israel, Korea, Republic of, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingCarcinoma, HepatocellularColombia, Israel, Taiwan, United States, Australia, Brazil, Chile, China, Denmark, France, Germany, Hong Kong, Hungary, Ireland, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Norway, Portugal, Puerto Rico, Spain, Thailand, Turke... and more
-
Merck Sharp & Dohme LLCActive, not recruitingSmall Cell Lung CancerPoland, Russian Federation, United States, Austria, Canada, Hungary, Israel, Italy, Korea, Republic of, Spain, Switzerland
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, HepatocellularKorea, Republic of, China, Hong Kong, Malaysia, Taiwan
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCGynecologic Oncology Group; European Network for Gynaecological Oncological...Active, not recruitingEndometrial NeoplasmsUnited States, Argentina, Austria, Belgium, Canada, Chile, China, Colombia, Czechia, Denmark, Finland, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Mexico, Norway, Poland, Russian Federation, Spain, Sweden, Taiwan, T... and more
-
Merck Sharp & Dohme LLCCompletedUrothelial Carcinoma Associated 1 RNA, Human
-
Merck Sharp & Dohme LLCNovartis PharmaceuticalsCompleted
-
Merck Sharp & Dohme LLCTerminated
-
Merck Sharp & Dohme LLCActive, not recruitingStomach NeoplasmsChina, Japan, Poland, Turkey, Brazil, United States, Argentina, Australia, Canada, Chile, Colombia, Costa Rica, Czechia, Denmark, France, Germany, Guatemala, Hong Kong, Hungary, Ireland, Israel, Italy, Korea, Republic of, Mexico, New Zealand and more
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMalignant MelanomaUnited States, Australia, Austria, Brazil, Canada, Chile, China, France, Germany, Israel, Italy, Korea, Republic of, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruiting
-
Merck Sharp & Dohme LLCWithdrawn
-
Merck Sharp & Dohme LLCRecruitingLymphoma, B-Cell | Lymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States, Australia, Canada, Israel, Italy, Germany
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingNonsquamous Non-small Cell Lung CancerChina
-
Merck Sharp & Dohme LLCEisai Inc.CompletedNon-small Cell Lung CancerChina
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMetastatic Non-Small Cell Lung CancerRussian Federation, Australia, United States, Argentina, Canada, Colombia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Portugal, Puerto Rico, Spain, United Kingdom
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Novartis PharmaceuticalsActive, not recruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationSpain, Italy, Austria, Netherlands, United Kingdom, Thailand, France, Belgium, China, Germany, Greece, Argentina, Turkey, Malaysia, Portugal, Brazil, United States, Hungary, India
-
Merck Sharp & Dohme LLCActive, not recruitingBladder CancerCanada, United States, Australia, Belgium, Denmark, France, Germany, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Sweden, Thailand, Turkey, Ukraine, United Kingdom
-
Thomas MarronRecruiting
-
UNICANCERFondation ARCActive, not recruitingMelanoma | Non Small Cell Lung Cancer | Head and Neck Squamous Cell CarcinomaFrance